Clinical Trials Browser

Phase 3 × Hypersensitivity × 90 days × Clear all

NCT06240741 2026-02-03

A Prospective, Open-label Study of [68Ga]Ga-DOTA-TATE in Patients With Neuroendocrine Neoplasms (NENs) and Healthy Volunteers in Japan

Phase 3 Completed

71 enrolled 37 charts

Hypersensitivity